Artia Global Partners’s Cidara Therapeutics CDTX Stock Holding History

Artia Global Partners’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-70,824	Closed	-$15.6M	–	53
2025 Q4	$15.6M	Buy	+70,824	New	+$11.4M	2.22%	13

Artia Global Partners's CDTX Position: Q1 2026 in Review

Artia Global Partners sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 70,824 shares — an estimated $15.6M sold.

Artia Global Partners first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $15.6M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Artia Global Partners reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Artia Global Partners sold 70,824 Cidara Therapeutics shares in Q1 2026, an estimated $15.6M.
Artia Global Partners first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Artia Global Partners's Cidara Therapeutics position peaked at $15.6M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Artia Global Partners's 13F filing for Q1 2026, filed 15 May 2026.